Brief: XVIVO Perfusion And MyCartis Announce Collaboration
July 17 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* MYCARTIS AND XVIVO PERFUSION AB ANNOUNCE A COLLABORATION
* XVIVO AND MYCARTIS ENGAGE TO DEVELOP A FAST DIAGNOSTIC
TEST TO
ASSESS THE QUALITY OF DONATED ORGANS BEFORE TRANSPLANTATION
Source text for Eikon: ID:nWkr4VqPq8
Further company coverage: XVIVO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength